Social Rx Connect is now on G-Cloud 12

We are delighted to announce our application to the G-Cloud 12 framework has been successful. Our social prescribing solution went live on the 28th of September.

The successful application has been a wonderful step for the company, securing a place on a valuable framework from Crown Commercial Service that takes away the need for a lengthy tender process.

 

Screenshot Social Rx Connect on G Cloud

About G-Cloud 12

G-Cloud 12 is a digital marketplace. The public sector in the UK can procure cloud-based computing services via this platform. The marketplace is essentially a large database of over 36,000 services and over 3,500 suppliers where the public sector can search, find and procure appropriate digital solutions.

But not only that, it sets public-sector organisations at ease the companies listed on the digital marketplace have been approved by the Commercial Crown Service.

Social Rx is a cloud-based software that enables organisations to fully organise and manage their social prescribing digitally. G-Cloud offers an easy way for these organisations to quickly access the information they need. The information on the Digital Marketplace is expansive, ranging from pricing information to user support, operational security, and supported browsers.

The Social Rx Connect software being accepted on G-Cloud 12 allows us to bring our software to more users across the country. “In 2020 we have seen the importance of digital solutions and how it can tackle difficulties in a socially-distanced world," CEO Mo Rahman says. "Even more, in a world where the NHS is greatly focussed on fighting against COVID-19, time-saving digital solutions have become a valuable commodity.”

We look forward to offering our software via Crown Commercial Service. Have a look at our solutions by going to the government’s digital marketplace.

Get in touch with us

Do you wish to learn more about our services and software solutions? Send us an email at info@socialrx.co.uk or fill out our contact form.


Leave a comment

Please note, comments must be approved before they are published